Does SIMVASTATIN Cause Hypertransaminasaemia? 61 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 61 reports of Hypertransaminasaemia have been filed in association with SIMVASTATIN (Simvastatin). This represents 0.2% of all adverse event reports for SIMVASTATIN.
61
Reports of Hypertransaminasaemia with SIMVASTATIN
0.2%
of all SIMVASTATIN reports
0
Deaths
32
Hospitalizations
How Dangerous Is Hypertransaminasaemia From SIMVASTATIN?
Of the 61 reports, 32 (52.5%) required hospitalization.
Is Hypertransaminasaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SIMVASTATIN. However, 61 reports have been filed with the FAERS database.
What Other Side Effects Does SIMVASTATIN Cause?
Myalgia (3,919)
Fatigue (2,066)
Arthralgia (1,775)
Drug interaction (1,744)
Nausea (1,676)
Rhabdomyolysis (1,616)
Dyspnoea (1,542)
Headache (1,470)
Drug hypersensitivity (1,433)
Muscular weakness (1,356)
What Other Drugs Cause Hypertransaminasaemia?
METHOTREXATE (436)
ACETAMINOPHEN (326)
PACLITAXEL (318)
CARBOPLATIN (304)
PEMBROLIZUMAB (231)
ATORVASTATIN (207)
CYCLOPHOSPHAMIDE (202)
PREDNISONE (198)
GEMCITABINE (196)
DEXAMETHASONE (169)
Which SIMVASTATIN Alternatives Have Lower Hypertransaminasaemia Risk?
SIMVASTATIN vs SINGULAIR
SIMVASTATIN vs SINTILIMAB
SIMVASTATIN vs SIPONIMOD
SIMVASTATIN vs SIPULEUCEL-T
SIMVASTATIN vs SIROLIMUS